We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
-7.37%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$65.6B
AUM Growth
-$4.01B
Cap. Flow
+$2.13B
Cap. Flow %
3.25%
Top 10 Hldgs %
17.81%
Holding
764
New
62
Increased
390
Reduced
214
Closed
64

Top Sells

Rank Stock Value
1
OCR
OMNICARE INC
OCR
+$369M
2
EMC
EMC CORPORATION
EMC
+$356M
3
ALL icon
Allstate
ALL
+$332M
4
CVS icon
CVS Health
CVS
+$325M
5
TEL icon
TE Connectivity
TEL
+$268M

Sector Composition

Rank Sector Weight
1 Financials 26.35%
2 Healthcare 15.13%
3 Technology 14.24%
4 Industrials 12.69%
5 Consumer Discretionary 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
176
PepsiCo
PEP
$186B
$85.4M 0.13%
905,785
-35,558
-4% -$3.38M
B
177
Barrick Mining
B
$62.2B
$83.5M 0.13%
13,122,944
+495,223
+4% +$3.72M
EA icon
178
Electronic Arts
EA
$52.4B
$83.3M 0.13%
1,229,429
-647,950
-35% -$45.4M
KRC icon
179
Kilroy Realty
KRC
$4.58B
$82.4M 0.13%
1,265,245
+118,617
+10% +$8.12M
CCEP icon
180
Coca-Cola Europacific Partners
CCEP
$46.5B
$80.7M 0.12%
1,669,556
+155,485
+10% +$7.56M
LOW icon
181
Lowe's Companies
LOW
$116B
$80.4M 0.12%
1,166,155
+1,083,055
+1,303% +$74.5M
PCG icon
182
PG&E
PCG
$47.8B
$78.1M 0.12%
1,480,022
+137,414
+10% +$7.02M
DEI icon
183
Douglas Emmett
DEI
$2.06B
$75.9M 0.12%
2,642,380
+248,160
+10% +$7.19M
NOC icon
184
Northrop Grumman
NOC
$77B
$74.8M 0.11%
450,782
+84,639
+23% +$14.2M
TIME
185
DELISTED
Time Inc.
TIME
$74M 0.11%
3,883,923
+318,415
+9% +$6.73M
WBC
186
DELISTED
WABCO HOLDINGS INC.
WBC
$72.1M 0.11%
687,599
+63,983
+10% +$7.49M
UNH icon
187
UnitedHealth
UNH
$382B
$72.1M 0.11%
621,136
-31,051
-5% -$3.72M
CW icon
188
Curtiss-Wright
CW
$27.7B
$70.7M 0.11%
1,133,278
+16,017
+1% +$1.08M
PARA
189
DELISTED
Paramount Global Class B
PARA
$70.1M 0.11%
1,756,292
-610,433
-26% -$29.6M
MOS icon
190
The Mosaic Company
MOS
$7.09B
$68.3M 0.1%
2,194,173
+176,728
+9% +$7.29M
KG
191
Kestrel Group
KG
$71.3M
$66.9M 0.1%
241,023
-8,593
-3% -$2.64M
WKC icon
192
World Kinect Corp
WKC
$1.96B
$64.9M 0.1%
1,813,063
+249,912
+16% +$10.4M
MD icon
193
Pediatrix Medical
MD
$2.16B
$63.4M 0.1%
825,549
+100,074
+14% +$8.08M
DVA icon
194
DaVita
DVA
$15.1B
$62.4M 0.1%
862,354
+46,488
+6% +$3.6M
SNX icon
195
TD Synnex
SNX
$19.4B
$61.6M 0.09%
1,448,380
+26,278
+2% +$1.02M
RAI
196
DELISTED
Reynolds American Inc
RAI
$61.5M 0.09%
1,390,125
-843,295
-38% -$35M
AAT
197
American Assets Trust
AAT
$1.49B
$60.9M 0.09%
1,490,371
+139,342
+10% +$5.61M
PYPL icon
198
PayPal
PYPL
$49.5B
$59.3M 0.09%
+1,909,627
New +$68.4M
CDW icon
199
CDW
CDW
$17.1B
$56.7M 0.09%
1,387,342
+319,793
+30% +$12.1M
CUB
200
DELISTED
Cubic Corporation
CUB
$56.5M 0.09%
1,347,655
+228,221
+20% +$9.88M

Similar funds

Boston Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Boston Partners held 764 positions worth $65.6B, down 5.8% from $69.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Partners deployed $2.13B of net new capital in Q3 2015, opening 62 new positions and adding to 390 existing holdings. Its largest new stake was WestRock Company: 5,830,276 shares worth $270M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was EMC CORPORATION, an estimated $356M trimmed.

  • Boston Partners's largest Q3 2015 buy was WestRock Company: 5,830,276 shares worth $270M.
  • Boston Partners added most to Johnson & Johnson in Q3 2015, an estimated $282M increase.
  • Boston Partners's biggest Q3 2015 reduction was EMC CORPORATION, cutting an estimated $356M.
  • Boston Partners fully exited OMNICARE INC in Q3 2015, selling an estimated $369M.
  • Boston Partners's ten largest holdings make up 18% of its $65.6B portfolio in Q3 2015.
  • Boston Partners opened 62 new positions and closed 64 in Q3 2015.
  • Boston Partners's portfolio value fell 5.8% quarter-over-quarter to $65.6B.

Based on Boston Partners's 13F filing for Q3 2015, filed 10 Nov 2015.